Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-29

Clinical Trial Update: Hydroxyethyl Starch and Renal Function After Hip Replacement Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial assessing hydroxyethyl starch and renal function in osteoarthritis patients undergoing hip replacement has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxyethyl starch (hydroxyethyl starch)

Snippet

Sponsor: Regional Hospital Holstebro | Conditions: Osteoarthritis | Phase 4 | Status: COMPLETED